Cargando…
Implementing a clozapine supply service in Australian community pharmacies: barriers and facilitators
BACKGROUND: Clozapine is the most effective antipsychotic for treatment-resistant schizophrenia, although serious adverse effects such as agranulocytosis and cardiomyopathy limit its use. In July 2015, Australian regulations changed to allow community-based prescribing and supply of clozapine for ma...
Autores principales: | Wilson, Bethany, McMillan, Sara S., Wheeler, Amanda J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685252/ https://www.ncbi.nlm.nih.gov/pubmed/31406580 http://dx.doi.org/10.1186/s40545-019-0180-3 |
Ejemplares similares
-
Australian Community Pharmacy Harm-Minimisation Services: Scope for Service Expansion to Improve Healthcare Access
por: McMillan, Sara S., et al.
Publicado: (2021) -
Australian community pharmacy services: a survey of what people with chronic conditions and their carers use versus what they consider important
por: McMillan, Sara S, et al.
Publicado: (2014) -
Experiences of goal planning in Australian community pharmacy settings for people experiencing mental illness: A qualitative study
por: Stewart, Victoria, et al.
Publicado: (2023) -
Bridging the gap between physical and mental illness in community pharmacy (PharMIbridge): protocol for an Australian cluster randomised controlled trial
por: Wheeler, Amanda J, et al.
Publicado: (2020) -
Qualitative study on the implementation of professional pharmacy services in Australian community pharmacies using framework analysis
por: Moullin, Joanna C., et al.
Publicado: (2016)